Description
B-Raf IN 1 inhibits both B-Raf and c-Raf, likely displaying anticancer activity.
Product Unit Size | Cost | Quantity | Stock |
---|
B-Raf IN 1 inhibits both B-Raf and c-Raf, likely displaying anticancer activity.
Cas No. | 950736-05-7 |
---|---|
Purity | ≥98% |
Formula | C29H24F3N5O |
Formula Wt. | 515.54 |
IUPAC Name | N-[3-(3-{4-[(Dimethylamino)methyl]phenyl}pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-3-(trifluoromethyl)benzamide |
Solubility | DMSO: ≥ 53 mg/mL |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Berger DM, Torres N, Dutia M, et al. Non-hinge-binding pyrazolo[1,5-a]pyrimidines as potent B-Raf kinase inhibitors. Bioorg Med Chem Lett. 2009 Dec 1;19(23):6519-23. PMID: 19864136.
Serum response factor inhibitor and MRTF-A bind...
Xanthine derivative; PDE inhibitor.
PI3K and HDAC inhibitor.
Triterpene saponin originally found in Bolboste...
c-MET inhibitor.
SMAC mimetic; PXR agonist, IAP inhibitor.
Calcitonin-family peptide, involved in vasodila...
Naphthalene; indirect STAT1 agonist.
2-methyl-1,4-naphthoquinone derivative
Penciclovir prodrug, nucleoside (guanosine) ana...
c-MET, Tie-2, VEGFR inhibitor.
Derivative of methyl caffeate, hydroxycinnamic ...
Enkephalinase inhibitor.
Microtubule polymerization inhibitor.
Fluoroquinolone; bacterial DNA gyrase inhibitor...
Nucleoside (deoxyuridine) analog; DNA chain ter...
Endogenous NMDA receptor antagonist.
Imidazole; 14-α demethylase inhibitor.
DPP4 inhibitor.
Purine derivative; CDK inhibitor.